Kantartzis Konstantinos, Rittig Killian, Balletshofer Bernd, Machann Jürgen, Schick Fritz, Porubska Katarina, Fritsche Andreas, Häring Hans-Ulrich, Stefan Norbert
Department of Internal Medicine, Division of Endocrinology, Metabolism, Pathobiochemistry, and Clinical Chemistry, Eberhard-Karls-University of Tübingen, Tübingen, Germany.
Clin Chem. 2006 Oct;52(10):1934-42. doi: 10.1373/clinchem.2006.067397. Epub 2006 Aug 17.
The metabolic effects of adiponectin, including insulin sensitivity, seem to become stronger with increasing adiposity. Adiposity may also affect the relationship of adiponectin concentrations with serum lipid profile; markers of inflammation, atherosclerosis, and endothelial function; and ectopic fat accumulation.
We measured plasma adiponectin concentrations, serum lipids, and serum markers of inflammation, atherosclerosis, and endothelial function in 242 Caucasians without type 2 diabetes. We also measured visceral adipose tissue with magnetic resonance tomography and liver and intramyocellular fat with (1)H magnetic resonance spectroscopy.
We divided the study participants into 2 groups: lean [mean (SE) total body fat, 26% (0.6%); n = 119] and obese [36% (0.6%); n = 123]. In the obese group, plasma adiponectin concentrations showed a strong positive association with concentrations of HDL cholesterol (P <0.0001) and negative associations with LDL cholesterol, triglycerides, high-sensitivity C-reactive protein, interleukin 6, apolipoprotein B(100), soluble E-selectin, soluble vascular cellular adhesion molecule 1, plasminogen activator inhibitor 1, leukocyte count, and liver and intramyocellular fat (all P <0.03). In the lean group, adiponectin showed a less strong association with HDL cholesterol (P = 0.005) and liver fat (P = 0.03) and no significant associations with the other variables (all P >0.10). High visceral adipose tissue was a strong predictor of low adiponectin concentrations, particularly in the obese group, and attenuated many of the significant relationships.
High adiponectin plasma concentrations are associated with favorable lipid profiles, decreased subclinical inflammation, decreased markers of atherosclerosis and endothelial function, and low ectopic fat accumulation, particularly in obese persons. Adiponectin may also have a concentration-related effect on the relationship between visceral adipose tissue and these metabolic characteristics, especially in obese persons.
脂联素的代谢效应,包括胰岛素敏感性,似乎会随着肥胖程度的增加而增强。肥胖也可能影响脂联素浓度与血清脂质谱、炎症、动脉粥样硬化和内皮功能标志物以及异位脂肪堆积之间的关系。
我们测量了242名无2型糖尿病的白种人的血浆脂联素浓度、血清脂质以及炎症、动脉粥样硬化和内皮功能的血清标志物。我们还通过磁共振断层扫描测量了内脏脂肪组织,并通过氢磁共振波谱测量了肝脏和肌内脂肪。
我们将研究参与者分为两组:瘦组[平均(标准误)全身脂肪,26%(0.6%);n = 119]和肥胖组[36%(0.6%);n = 123]。在肥胖组中,血浆脂联素浓度与高密度脂蛋白胆固醇浓度呈强正相关(P <0.0001),与低密度脂蛋白胆固醇、甘油三酯、高敏C反应蛋白、白细胞介素6、载脂蛋白B(100)、可溶性E选择素、可溶性血管细胞黏附分子1、纤溶酶原激活物抑制剂1、白细胞计数以及肝脏和肌内脂肪呈负相关(所有P <0.03)。在瘦组中,脂联素与高密度脂蛋白胆固醇(P = 0.005)和肝脏脂肪(P = 0.03)的相关性较弱,与其他变量无显著相关性(所有P >0.10)。高内脏脂肪组织是低脂联素浓度的强预测指标,尤其是在肥胖组中,并减弱了许多显著关系。
高血浆脂联素浓度与有利的脂质谱、亚临床炎症减少、动脉粥样硬化和内皮功能标志物降低以及异位脂肪堆积减少相关,尤其是在肥胖人群中。脂联素也可能对内脏脂肪组织与这些代谢特征之间的关系产生浓度相关效应,尤其是在肥胖人群中。